In the present study, we tested whether participants in the Genetics of Hypertension Associated Treatment (GenHAT) Study with different NOS3 genotypes randomized to amlodipine treatment had different outcomes with regard to five CVD measures than their counterparts who were randomized to lisinopril or chlorthalidone. Here, NOS3 is linked to hypertensive disorder.